Literature DB >> 1426096

Characteristics of a novel rat anti-mouse platelet monoclonal antibody: application to studies of megakaryocytes.

S A Burstein1, P Friese, T Downs, R L Mei.   

Abstract

Using murine platelets as an immunogen, a rat monoclonal antibody (designated 4A5) that recognizes only murine blood platelets and marrow megakaryocytes was developed. The extent of binding of 4A5 to platelets was dependent upon their state of activation. Following phorbol ester, ionophore, or thrombin stimulation of resting platelets, a decrease of > 50% in the binding of 4A5 was observed by flow cytometry. This decrease in antibody binding to the platelets was accompanied by an increase in antibody released into the platelet-free supernatant following platelet activation. When platelets were first radioiodinated, followed by activation and incubation of the platelet-free supernatant with 4A5-derivatized beads, no precipitable counts were observed compared with control resting platelets. This suggests that antibody release was related to an activation-dependent conformational change in the 4A5 epitope. Following solubilization of biotinylated platelets, 4A5 bound to an 80-kd membrane protein. Immunohistochemical studies with 4A5 showed that megakaryocytes could be identified both in vitro and ex vivo. When marrow was first stained histochemically with 4A5 followed by staining for acetylcholinesterase, the distribution of stained cells was similar. Flow cytometric analysis using 4A5 and propidium iodide showed that the antibody could be used to identify megakaryocytes for ploidy analysis in vivo or in vitro. 4A5 was capable of inducing a moderate thrombocytopenia in mice compared with polyclonal anti-platelet serum. When bound to plastic or to magnetic beads, 4A5 could be used to purify murine megakaryocytes to homogeneity. The data suggest that monoclonal antibody 4A5 will be useful in quantitative studies of murine platelets and megakaryocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426096

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  5 in total

1.  Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line.

Authors:  M J Weiss; C Yu; S H Orkin
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

2.  A role for cyclin D3 in the endomitotic cell cycle.

Authors:  J M Zimmet; D Ladd; C W Jackson; P E Stenberg; K Ravid
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

3.  Enrichment of functionally distinct mouse hematopoietic progenitor cell populations using CD62L.

Authors:  Scott Cho; Gerald J Spangrude
Journal:  J Immunol       Date:  2011-10-12       Impact factor: 5.422

4.  A constitutively activated erythropoietin receptor stimulates proliferation and contributes to transformation of multipotent, committed nonerythroid and erythroid progenitor cells.

Authors:  G D Longmore; P N Pharr; H F Lodish
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

5.  Expression of c-MYC under the control of GATA-1 regulatory sequences causes erythroleukemia in transgenic mice.

Authors:  R C Skoda; S F Tsai; S H Orkin; P Leder
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.